The value of aortic valve replacement in elderly patients: An economic analysis

References 

1. Arias E. United States Life Tables, 2001 (National Vital Statistics Reports). Natl Vital Stat Rep. 2004;52(14):1–38
   • MEDLINE
2. National Center for Health Statistics (US). Vital statistics of the United States: annual statistical abstract of the United States: 2006. Section 2, vital statistics.
3. Murphy KM, Topel RH. The value of health and longevity. Cambridge (MA): National Bureau of Economic Research; 2005;NBER working papers series No. 11405.
4. Dockins C, Maguire K, Simon N, Sullivan M. Value of statistical life analysis and environmental policy: a white paper. Washington, DC: Environmental Protection Agency (US), National Center for Environmental Economics; 2004;
5. Wu Y, Jin R, Gao G, Grunkemeier GL, Starr A. Cost-effectiveness of aortic heart valve replacement in the elderly. J Thorac Cardiovasc Surg. 2007;133:608–613
   • Abstract
   • Full Text
   • Full-Text PDF (332 KB)
   • CrossRef
6. Wu Y, Grunkemeier GL. Statistical analysis of the results of heart valve replacement. Expert Rev Cardiovasc Ther. 2003;1:559–568
   • MEDLINE
   • CrossRef
7. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol. 1982;1:61–80
   • CrossRef
8. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? (Tentative guidelines for using clinical and economic evaluations). CMAJ. 1992;146:473–481
   • MEDLINE
9. Murphy KM, Topel R. Medical research: What’s it worth?. Milken Institute Review. 2000;23–30First quarter.
10. Brannon II. What is a life worth?. Regulation. 2004;27:60–63
11. Ackerman F, Heinzerling L. If it exists, it’s getting bigger: revising the value of a statistical life. Boston: Global Development and Environment Institute; 2003;Working paper No. 01-06.
12. Murphy KM, Topel RH. In: Measuring the gains from medical research: an economic approach. London: University of Chicago Press; 2003;p. 1–240
13. Cutler DM, McClellan M. Is technological change in medicine worth it?. Health Aff (Millwood). 2001;20:11–29
    • MEDLINE
    • CrossRef
14. Cutler DM. In: Your money or your life: strong medicine for America’s health care system. Oxford, UK: Oxford University Press; 2004;p. 176
15. Mrozek J, Taylor L. What determines the value of life? (A meta-analysis). J Policy Analysis Manage. 2002;21:253–282
16. Krupnick A, Cropper M, Alberini A, Simon N, O’Brien B, Goeree R. Age, health and the willingness to pay for mortality risk reductions: a contingent valuation survey of Ontario residents. J Risk Uncertainty. 2002;24:161–175
17. Miller TR. The plausible range for the value of life—red herrings among the mackerel. J Forensic Econ. 1990;3:17–40
18. Fisher A, Chestnut L, Violette D. The value of reducing risks of death: a note on new evidence. J Policy Anal Manage. 1989;8:88–100
    • CrossRef
19. Leeth JD, Ruser J. Compensating wage differentials for fatal and nonfatal injury risk by gender and race. J Risk Uncertainty. 2003;27:257–277
20. Viscusi WK. The value of risks to life and health. J Econ Lit. 1993;31:1912–1946
21. Viscusi WK, Aldy JE. The value of a statistical life: a critical review of market estimates throughout the world. Cambridge (MA): National Bureau of Economic Research; 2003;NBER working papers series No. W9487. Available from: URL: http://ssrn.com/abstract=379270
22. Viscusi WK. The value of life in legal contexts: survey and critique. Am Law Econ Rev. 2000;2:195–210
23. Environmental Protection Agency Science Advisory Board (US), Environmental Economics Advisory Committee Panel for Review of the White Paper. Valuing the benefits of fatal cancer risk reduction. Washington: The Agency; 2000;
24. Alberini A, Cropper M, Krupnick A, Simon NB. Does the Value of a Statistical Life Vary with Age and Health Status? (Evidence from the United States and Canada). Journal of Environmental Economics and Management. 2004;48:769–792